Loading news article.

FilingSEC EDGAR8-K

Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer

Oct 22, 2026, 19:33 ET · SEC accepted

StageExecutive Appointment

Filing content

Retension Pharmaceuticals announced the appointment of Robert Wong as Chief Accounting Officer, effective November 2, 2026, with an annual base salary of $360,000 and a stock option award for 25,000 shares.

AI summary of the filing. Please also check the source.

Related companies

RETENSION PHARMACEUTICALS INCRTSNView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…